DK160511C - Fremgangsmaade og reagens til bestemmelse af antithrombin-bm - Google Patents

Fremgangsmaade og reagens til bestemmelse af antithrombin-bm

Info

Publication number
DK160511C
DK160511C DK237282A DK237282A DK160511C DK 160511 C DK160511 C DK 160511C DK 237282 A DK237282 A DK 237282A DK 237282 A DK237282 A DK 237282A DK 160511 C DK160511 C DK 160511C
Authority
DK
Denmark
Prior art keywords
antithrombin
reagent
determination
Prior art date
Application number
DK237282A
Other languages
English (en)
Other versions
DK160511B (da
DK237282A (da
Inventor
Helmut Lill
Juergen Schrenk
Peter Wunderwald
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19803038163 external-priority patent/DE3038163A1/de
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of DK237282A publication Critical patent/DK237282A/da
Publication of DK160511B publication Critical patent/DK160511B/da
Application granted granted Critical
Publication of DK160511C publication Critical patent/DK160511C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81Protease inhibitors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81Protease inhibitors
    • G01N2333/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/811Serine protease (E.C. 3.4.21) inhibitors
    • G01N2333/8121Serpins
    • G01N2333/8128Antithrombin III
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/948Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/974Thrombin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/38Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, e.g. Konjac gum, Locust bean gum, Guar gum
    • G01N2400/40Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Neurosurgery (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK237282A 1980-10-09 1982-05-26 Fremgangsmaade og reagens til bestemmelse af antithrombin-bm DK160511C (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DE19803038163 DE3038163A1 (de) 1980-10-09 1980-10-09 Thrombininhibitor, seine herstellung und verwendung
DE3038163 1980-10-09
DE3050268 1981-08-04
DE3050268 1981-08-04
DE8100170 1981-10-08
PCT/DE1981/000170 WO1982001377A1 (en) 1980-10-09 1981-10-08 Method for determining a bm-antithrombin

Publications (3)

Publication Number Publication Date
DK237282A DK237282A (da) 1982-05-26
DK160511B DK160511B (da) 1991-03-18
DK160511C true DK160511C (da) 1991-09-30

Family

ID=25788386

Family Applications (1)

Application Number Title Priority Date Filing Date
DK237282A DK160511C (da) 1980-10-09 1982-05-26 Fremgangsmaade og reagens til bestemmelse af antithrombin-bm

Country Status (6)

Country Link
US (1) US4496653A (da)
EP (1) EP0049877B1 (da)
JP (1) JPH0258920B2 (da)
DE (1) DE3163764D1 (da)
DK (1) DK160511C (da)
WO (1) WO1982001377A1 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3407280A1 (de) * 1984-02-28 1985-09-19 Gödecke AG, 1000 Berlin Testsatz zur bestimmung der aktivierten partiellen thromboplastinzeit (ptt) mit erhoehter heparinempfindlichkeit
DE3512909A1 (de) * 1985-04-11 1986-10-23 Behringwerke Ag, 3550 Marburg Verfahren zur bestimmung von plasminogenaktivatoren (pa)
NL8902406A (nl) * 1989-09-27 1991-04-16 Hendrik Coenraad Hemker Prof D Werkwijze voor het bepalen van de endogene trombinepotentiaal van plasma, en bloed alsmede een bij deze werkwijze te gebruiken kit.
US5595735A (en) * 1990-05-23 1997-01-21 Johnson & Johnson Medical, Inc. Hemostatic thrombin paste composition
EP0509086B1 (en) * 1990-11-05 1995-04-12 Dade Produktions AG A method to determine the concentration of anticoagulants
DE4203980A1 (de) * 1992-02-11 1993-08-12 Max Planck Gesellschaft Verfahren zur bestimmung von hirudin und synthetischen thrombininhibitoren
AT397391B (de) * 1992-05-15 1994-03-25 Immuno Ag Verwendung von prothrombinfragmenten
AU4405293A (en) * 1992-06-05 1994-01-04 Barbara M. Alving Test for quantitative thrombin time
US5476771A (en) * 1993-02-22 1995-12-19 The United States Of America As Represented By The Secretary Of The Army Test for quantitative thrombin time
US5308755A (en) * 1992-06-08 1994-05-03 Research Corporation Technologies, Inc. Method for measuring heparin
US5985582A (en) * 1997-12-09 1999-11-16 Sigma-Aldrich Co. Thrombin-based assay for antithrombin III
EP3198280B1 (en) 2014-09-26 2021-05-26 Abbott Point Of Care, Inc. Sensors for assaying coagulation in fluid samples
WO2016049552A1 (en) 2014-09-26 2016-03-31 Abbott Point Of Care Inc. Cartridge device identification for coagulation assays in fluid samples
WO2016049515A1 (en) 2014-09-26 2016-03-31 Abbott Point Of Care Inc. Microfabricated device with micro-environment sensors for assaying coagulation in fluid samples
WO2016049533A1 (en) 2014-09-26 2016-03-31 Abbott Point Of Care Inc. Cartridge device with fluidic junctions for coagulation assays in fluid samples
CN106999930B (zh) 2014-09-26 2020-09-08 雅培医护站股份有限公司 用于测定流体样本中的凝结的具有分段射流的盒设备
EP4043879A1 (en) 2014-09-26 2022-08-17 Abbott Point Of Care Inc Single channel cartridge device for coagulation assays in fluid samples
WO2016049557A1 (en) 2014-09-26 2016-03-31 Abbott Point Of Care Inc. Ellagic acid formulations for use in coagulation assays

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH622286A5 (da) * 1975-06-23 1981-03-31 Pentapharm Ag
SE419871B (sv) * 1975-12-01 1981-08-31 Pharmacia Ab Sett att bestemma aktiviteten hos faktor xa-inhibitor i blod
DE2601372C3 (de) * 1976-01-15 1980-03-27 Behringwerke Ag, 3550 Marburg Verfahren zur Bestimmung von Antithrombin III
DE2812943C3 (de) * 1978-03-23 1981-05-14 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren und Reagens zur Bestimmung der biologischen Aktivität von Heparin im Plasma
US4216142A (en) * 1978-12-18 1980-08-05 Abbott Laboratories Chromogenic substrates for the proteolytic enzymes
CA1136620A (en) * 1979-01-08 1982-11-30 Ulf P.F. Lindahl Heparin fragments having selective anticoagulation activity
DE3061860D1 (en) * 1979-04-24 1983-03-17 Marcel Jozefonvicz Process for the determination of proteases and antiproteases
CA1171375A (en) * 1980-09-15 1984-07-24 Ulf P.F. Lindahl Oligosaccharides having selective anticoagulation activity

Also Published As

Publication number Publication date
US4496653A (en) 1985-01-29
EP0049877A1 (de) 1982-04-21
DK160511B (da) 1991-03-18
JPS57501510A (da) 1982-08-26
DK237282A (da) 1982-05-26
JPH0258920B2 (da) 1990-12-11
WO1982001377A1 (en) 1982-04-29
EP0049877B1 (de) 1984-05-23
DE3163764D1 (en) 1984-06-28

Similar Documents

Publication Publication Date Title
DK160511C (da) Fremgangsmaade og reagens til bestemmelse af antithrombin-bm
DK137382A (da) Elektrolyt og fremgangsmaade til elektroafsaetning af kobber
DK372178A (da) Fremgangsmaade og reagens til bestemmelse af alfa-amylase
DK159407C (da) Fremgangsmaade og indretning til bestemmelse af antigeners eller antistoffers tilstedevaerelse
DK89282A (da) Holder og fremgangsmaade til opsaetning af paneler
DK16082A (da) Polymere af polyketenacetaler og polyoler
NO163426C (no) Lyseringsreagens og fremgangsmaate ved lysering.
DK159415C (da) Fremgangsmaade til erkendelse og identifikation af objekter
DK315679A (da) Fremgangsmaade og reagens til kvantitativ enzymatisk bestemmelse af adenosindiphosphat
DK149475C (da) Fremgangsmaade og reagens til bestemmelse af den biologiske aktivitet af herapin i plasma
DK158526C (da) Reagens til lipasebestemmelse og fremgangsmaade til fremstilling deraf
NL191340C (nl) Werkwijze en reagens voor endotoxine bepaling.
DK203988A (da) Forbindelse, reagens og fremgangsmaade til bestemmelse af kationer
DK150719C (da) Fremgangsmaade og reagens til prothrombinbestemmelse
DK51481A (da) Fremgangsmaade til bestemmelse af carcinoembryonisk antigen
DK203788A (da) Reagens og fremgangsmaade til bestemmelse af kationer
DK144856C (da) Fremgangsmaade og reagens til bestemmelse af triglycerider
DK53581A (da) Fremgangsmaade til fastgoerelse af facademurvaerk og boesning til gennemfoerelse af fremgangsmaaden
DK98584A (da) Fremgangsmaade til detektering af aendret dna
DK565981A (da) Kommutator og fremgangsmaade til fremstilling deraf
IS2700A7 (is) Efni afleidd af Pyrrolidin og aðferð til framleiðslu þeirra
DK39281A (da) Fremgangsmaade til fremstilling af 17alfa-acyloxy-5beta-corticoider og 17alfa-acyloxy-5alfa-corticoider
DK509882A (da) Konstruktionselement og fremgangsmaade til fremstilling af samme
DK391779A (da) Fremgangsmaade til paavisning og bestemmelse af et komplementbindende antistof samt reagens til gennemfoerelse af fremgangsmaaden
DK271582A (da) Fremgangsmaade og komposition til fremstilling af asbestfrie genstande

Legal Events

Date Code Title Description
PBP Patent lapsed